New patent issued in Hong Kong around HBV resistance announced!

Advanced Biological Laboratories has been granted additional patents in Hong Kong (HK1121187) to further protect its intellectual property and reinforce the already existing core patent entitled ”

Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof” (US Patent 8,367,317, Publication nº US8367317 B2).